Global Travelers Vaccines Sales Market Report 2020

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The classification of Travelers Vaccines includes Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine and other vaccines. The proportion of Hepatitis Vaccine in 2016 is about 28.94%, the proportion of Japanese Encephalitis Vaccine in 2016 is about 15.67%, and the proportion of other vaccine in 2016 is about 24.55%.

Market Analysis and Insights: Global Travelers Vaccines Market
The global Travelers Vaccines market size is projected to reach US$ 5127.6 million by 2026, from US$ 3091.3 million in 2020, at a CAGR of 8.8% during 2021-2026.

Global Travelers Vaccines Scope and Market Size
The global Travelers Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Travelers Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Travelers Vaccines market is segmented into
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other

Segment by End Users, the Travelers Vaccines market is segmented into
Tourists
Students
Workers
Others

The Travelers Vaccines market is analysed and market size information is provided by regions (countries). Segment by End Users, the Travelers Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by End Users segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Travelers Vaccines Market Share Analysis
Travelers Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Travelers Vaccines business, the date to enter into the Travelers Vaccines market, Travelers Vaccines product introduction, recent developments, etc.

The major vendors covered:
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai